Molecular Docking Technique Assisted Discovery of Some Hydroxylated Chalcone Molecules as α-glucosidase Inhibitors
Abstract
The present study involved exploration of the inhibitory potential of some A-ring hydroxylated chalcone compounds against PDB ID: 2QMJ file (Maltase-glucoamylase in complex with acarbose) with the assistance of iGEMDOCK (Genetic Evolutionary Method for Molecular Docking) software. The present study highlighted the immense potentials of several unexplored hydroxyl group (in ring-A) containing chalcones in successfully inhibiting the one of the most effective anti-hyperglycemic based enzymatic target α-glucosidase. The research has pointed out several key structural features which are truly essential for inhibiting the biological target, thereby resulting in expressing significantly better management of hyperglycemic surge. The type, position and the number of substituents present on the aromatic ring-B of the benzylideneacetophenone scaffold have played enormous function in mediating the pharmacological responses by directly interacting with the amino acid residues (ASP443, ASP542, ARG526, HIS600, TRP406, GLN603, and TYR605) present in the active site of the enzyme. The study outcomes will positively inspire the medicinal chemists and allied pharmaceutical researchers across the globes who are actively involved in the vast area of drug design, discovery, and development. The emerging docking results will provide directions towards effectual development of low-molecular-weight ligands in the anti-diabetic pharmacotherapeutics.
Keywords: Chalcone, α-glucosidase, diabetes, hypoglycemic, docking, inhibitor
Cite this Article
Santosh S. Chhajed, Neha A. Salunke, Animeshchandra G.M. Haldar, Kanhaiya M. Dadure, Debarshi Kar Mahapatra. Molecular Docking Technique Assisted Discovery of Some Hydroxylated Chalcone Molecules as α-glucosidase Inhibitors. Research & Reviews: A Journal of Drug Design & Discovery. 2019; 6(1): 34–38p
Downloads
Additional Files
Published
Issue
Section
License
Declaration and Copyright Transfer Form
(to be completed by authors)
I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.
- I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
- I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
- I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
- I/We also agree to the authorship of the article in the following order:
Author’s name
1. ________________
2. ________________
3. ________________
4. ________________
| We Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal. |